What is the appropriate treatment for oral thrush?

Treatment of Oral Thrush

For mild oral thrush, use clotrimazole troches 10 mg five times daily for 7–14 days; for moderate-to-severe disease, use oral fluconazole 100–200 mg daily for 7–14 days. 1, 2

Mild Disease: Topical Therapy First-Line

For patients with mild symptoms and limited oral involvement, topical agents are highly effective and avoid systemic exposure:

• Clotrimazole troches 10 mg five times daily for 7–14 days are the preferred first-line topical treatment (strong recommendation, high-quality evidence). 1, 2

• Miconazole mucoadhesive buccal tablet 50 mg applied once daily for 7–14 days is equally effective and offers the convenience of once-daily dosing (strong recommendation, high-quality evidence). 1, 2

• Alternative topical options for patients who cannot tolerate clotrimazole or miconazole include:

  • Nystatin suspension 100,000 U/mL, 4–6 mL swished four times daily for 7–14 days 1, 2, 3
  • Nystatin pastilles 200,000 U each, 1–2 pastilles four times daily for 7–14 days 1, 2, 3

Critical caveat: Nystatin should not be used for moderate-to-severe disease because it is inadequate and delays appropriate systemic therapy. 2

Moderate-to-Severe Disease: Systemic Therapy Required

When patients present with extensive oral involvement, difficulty swallowing, or significant symptoms:

• Oral fluconazole 100–200 mg once daily for 7–14 days is the treatment of choice (strong recommendation, high-quality evidence). 1, 2, 3

• This regimen is superior to topical agents in achieving rapid symptom resolution and mycological cure. 1, 2

• A single 150 mg dose of fluconazole has shown 96.5% improvement in palliative care patients with advanced cancer, though this is not the standard guideline-endorsed duration. 4

Fluconazole-Refractory Disease: Escalation Strategy

If symptoms persist after 7–14 days of fluconazole therapy, escalate to second-line agents:

• Itraconazole solution 200 mg once daily OR posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days (strong recommendation, moderate-quality evidence). 1, 2, 3

• Alternative oral agents include voriconazole 200 mg twice daily OR amphotericin B deoxycholate oral suspension 100 mg/mL four times daily (strong recommendation, moderate-quality evidence). 1, 2, 3

• For severe refractory cases, intravenous therapy may be necessary:

  • Echinocandins: caspofungin (70 mg loading dose, then 50 mg daily), micafungin (100 mg daily), or anidulafungin (200 mg loading dose, then 100 mg daily) 1, 2
  • IV amphotericin B deoxycholate 0.3 mg/kg daily 1, 2
  • These IV options carry a weak recommendation with moderate-quality evidence. 1, 2

Special Populations and Adjunctive Measures

Denture Wearers

• Mandatory denture disinfection must accompany antifungal therapy to prevent treatment failure and rapid relapse (strong recommendation, moderate-quality evidence). 2, 3
• Failure to disinfect dentures is a frequent cause of treatment failure. 2

HIV-Infected Patients

• Initiate or optimize antiretroviral therapy to reduce the incidence of recurrent oral candidiasis (strong recommendation, high-quality evidence). 1, 2, 3

Recurrent Infections

• Chronic suppressive therapy with fluconazole 100 mg three times weekly is recommended only for patients with recurrent infections after addressing underlying risk factors (strong recommendation, high-quality evidence). 1, 2, 3
• Chronic suppression is usually unnecessary if predisposing factors are corrected. 1

Common Pitfalls to Avoid

• Do not use nystatin for moderate-to-severe disease—it is inadequate and delays appropriate systemic therapy. 2

• Always disinfect dentures in denture wearers—this is a frequent cause of treatment failure when omitted. 2, 3

• Do not assume all oral white lesions are thrush—confirm diagnosis with clinical presentation and, when uncertain, culture or microscopy. 5

• Recognize treatment-resistant cases early—if no improvement after 7–14 days, escalate therapy rather than continuing the same regimen. 3, 6